Bouvel Investment Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-90,992
Closed -$2.52M 75
2025
Q1
$2.52M Buy
90,992
+26,629
+41% +$257K 0.95% 48
2024
Q4
$765K Sell
64,363
-26,629
-29% -$454K 0.28% 73
2024
Q3
$2.52M Sell
90,992
-2,768
-3% -$69.3K 0.95% 48
2024
Q2
$2.24M Sell
93,760
-428
-0.5% -$10K 0.87% 48
2024
Q1
$1.66M Sell
94,188
-130
-0.1% -$1.92K 0.72% 49
2023
Q4
$1.49M Buy
94,318
+3,929
+4% +$40.6K 0.7% 51
2023
Q3
$777K Buy
90,389
+989
+1% +$7.03K 0.42% 68
2023
Q2
$705K Buy
+89,400
New +$622K 0.39% 64

Other funds holding ASPN

Bouvel Investment Partners's ASPN Position: Q2 2025 in Review

Bouvel Investment Partners sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 90,992 shares — an estimated $2.52M sold.

Bouvel Investment Partners first reported a position in ASPN in Q2 2023 and held it in 8 quarters. The position peaked at $2.52M in Q1 2025. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Bouvel Investment Partners reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Bouvel Investment Partners sold 90,992 Aspen Aerogels shares in Q2 2025, an estimated $2.52M.
  • Bouvel Investment Partners first reported a position in Aspen Aerogels in Q2 2023 and held it in 8 quarters.
  • Bouvel Investment Partners's Aspen Aerogels position peaked at $2.52M in Q1 2025.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Bouvel Investment Partners's 13F filing for Q2 2025, filed 11 Jul 2025.